Popular weight-loss drugs may help protect against a deadly disease, doctor says

A breast cancer surgeon stated that GLP-1 receptor agonist drugs, including Ozempic and Wegovy, may reduce cancer recurrence risk through their effects on body mass index, estrogen levels, and inflammation. The drugs are approved by the FDA for weight management and diabetes treatment. The surgeon did not present new clinical trial data or peer-reviewed research findings in the statement.

Next story